Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Steward

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Best Practice & Research. Clinical Haematology|May 4, 2002
Clinical relevance of MRD in children undergoing allogeneic stem cell transplantation for ALLNick Goulden, Colin Steward
Clinical Dysmorphology|August 4, 2009
Dysmorphology of Barth syndromeRob Hastings, Colin Steward, Beverly Tsai-Goodman, et al.
British Journal of Haematology|June 24, 2009
Dismal long-term prognosis for children with refractory acute myeloid leukaemia treated with gemtuzumab ozogamicin and stem cell transplantation: where now?Keith Sibson, Colin Steward, John Moppett, et al.
Blood|February 21, 2004
Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposureBrigitta Versluys, Rajat Bhattacharaya, Colin Steward, et al.
Midwives|June 5, 2014
What is Barth syndrome?Vanessa Garratt, Debbie Riddiford, Colin Steward, et al.
Archives of Disease in Childhood|February 12, 2016
Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997-2003Jack Bartram, Rachel Wade, Ajay Vora, et al.
Blood|February 4, 2017
Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplantPrashant Hiwarkar, Persis Amrolia, Ponni Sivaprakasam, et al.
The Journal of Experimental Medicine|August 3, 2005
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramersMark Cobbold, Naeem Khan, Batoul Pourgheysari, et al.
EMBO Reports|February 17, 2025
Tafazzin regulates neutrophil maturation and inflammatory responsePrzemysław Zakrzewski, Christopher M Rice, Kathryn Fleming, et al.
British Journal of Haematology|January 6, 2016
UK experience of unrelated cord blood transplantation in paediatric patientsPaul Veys, Robert Danby, Ajay Vora, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Haematology|May 4, 2002
Clinical relevance of MRD in children undergoing allogeneic stem cell transplantation for ALLNick Goulden, Colin Steward
Clinical Dysmorphology|August 4, 2009
Dysmorphology of Barth syndromeRob Hastings, Colin Steward, Beverly Tsai-Goodman, et al.
British Journal of Haematology|June 24, 2009
Dismal long-term prognosis for children with refractory acute myeloid leukaemia treated with gemtuzumab ozogamicin and stem cell transplantation: where now?Keith Sibson, Colin Steward, John Moppett, et al.
Blood|February 21, 2004
Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposureBrigitta Versluys, Rajat Bhattacharaya, Colin Steward, et al.
Midwives|June 5, 2014
What is Barth syndrome?Vanessa Garratt, Debbie Riddiford, Colin Steward, et al.
Archives of Disease in Childhood|February 12, 2016
Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997-2003Jack Bartram, Rachel Wade, Ajay Vora, et al.
Blood|February 4, 2017
Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplantPrashant Hiwarkar, Persis Amrolia, Ponni Sivaprakasam, et al.
The Journal of Experimental Medicine|August 3, 2005
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramersMark Cobbold, Naeem Khan, Batoul Pourgheysari, et al.
EMBO Reports|February 17, 2025
Tafazzin regulates neutrophil maturation and inflammatory responsePrzemysław Zakrzewski, Christopher M Rice, Kathryn Fleming, et al.
British Journal of Haematology|January 6, 2016
UK experience of unrelated cord blood transplantation in paediatric patientsPaul Veys, Robert Danby, Ajay Vora, et al.
Pageof 2